Health Canada inspection
Neuraxpharm Pharmaceuticals S.L.: Health Canada inspection of Jan 26, 2026
Health Canada · GMP · rating I
Key facts
| Establishment | Neuraxpharm Pharmaceuticals S.L. |
|---|---|
| City | Sant Joan Despi |
| Province | Barcelona |
| Country | Spain |
| Program | GMP |
| Start date | Jan 26, 2026 |
| Rating | I |
| Rating description | Inspection in progress |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.